279 related articles for article (PubMed ID: 12010622)
1. Pharmacologic management of gastroesophageal reflux disease.
Ramakrishnan A; Katz PO
Curr Gastroenterol Rep; 2002 Jun; 4(3):218-24. PubMed ID: 12010622
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic Management of Gastroesophageal Reflux Disease.
Ramakrishnan A; Katz PO
Curr Treat Options Gastroenterol; 2002 Aug; 5(4):301-310. PubMed ID: 12095478
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
[TBL] [Abstract][Full Text] [Related]
4. Long-term management of gastroesophageal reflux disease and its complications.
Richter JE
Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor.
Freston JW
Am J Med; 2004 Sep; 117 Suppl 5A():14S-22S. PubMed ID: 15478848
[TBL] [Abstract][Full Text] [Related]
6. Treatment of gastroesophageal reflux disease.
Guimarães EV; Marguet C; Camargos PA
J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S133-45. PubMed ID: 17136289
[TBL] [Abstract][Full Text] [Related]
7. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
8. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
9. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
10. Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease.
Richter JE
Am J Med; 2003 Aug; 115 Suppl 3A():179S-187S. PubMed ID: 12928099
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
Katz PO
Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
[TBL] [Abstract][Full Text] [Related]
12. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
Pohle T; Domschke W
Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
[TBL] [Abstract][Full Text] [Related]
13. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
Stein HJ; Kauer WK; Feussner H; Siewert JR
J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
[TBL] [Abstract][Full Text] [Related]
14. [Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease].
Maev IV; Balashova NN; Busarova GA
Klin Med (Mosk); 2003; 81(9):54-9. PubMed ID: 14598594
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children.
Tolia V; Ferry G; Gunasekaran T; Huang B; Keith R; Book L
J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S308-18. PubMed ID: 12607791
[TBL] [Abstract][Full Text] [Related]
16. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
Watson TJ; Peters JH
Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
[TBL] [Abstract][Full Text] [Related]
17. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)?
Spechler SJ
Dig Dis; 2014; 32(1-2):156-63. PubMed ID: 24603402
[TBL] [Abstract][Full Text] [Related]
18. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Caro JJ; Salas M; Ward A
Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
[TBL] [Abstract][Full Text] [Related]
20. [Gastroesophageal reflux disease refractory to esomeprazole].
Velasco MJ; Ortiz V; Ponce J
Gastroenterol Hepatol; 2005 Feb; 28(2):65-7. PubMed ID: 15710084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
